# Gottfried Rudofsky

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gottfried-rudofsky/

## Facts

| Field | Value |
| --- | --- |
| Citations | 10,304 |
| Field | Peripheral Artery Disease Management |
| h-index | 44 |
| i10-index | 129 |
| Last Known Institution | Kantonsschule Olten |
| OpenAlex ID | https://openalex.org/A5047494174 |
| ORCID iD | 0000-0002-2576-7190 |
| Works | 332 |

## Researcher papers

- [Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity](https://scholariq.org/papers/effect-of-continued-weekly-subcutaneous-semaglutide-vs-placebo-on-weight-loss/)
- [A mechanism converting psychosocial stress into mononuclear cell activation](https://scholariq.org/papers/a-mechanism-converting-psychosocial-stress-into-mononuclear-cell-activation/)
- [snRNA-seq reveals a subpopulation of adipocytes that regulates thermogenesis](https://scholariq.org/papers/snrna-seq-reveals-a-subpopulation-of-adipocytes-that-regulates-thermogenesis/)
- [Difficulties in emotion regulation across the spectrum of eating disorders](https://scholariq.org/papers/difficulties-in-emotion-regulation-across-the-spectrum-of-eating-disorders/)
- [Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial](https://scholariq.org/papers/efficacy-and-safety-of-oral-semaglutide-with-flexible-dose-adjustment-versus/)
- [Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial](https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled-2/)
- [Mental Health Among Medical Professionals During the COVID-19 Pandemic in Eight European Countries: Cross-sectional Survey Study](https://scholariq.org/papers/mental-health-among-medical-professionals-during-the-covid-19-pandemic-in-eight/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg](https://scholariq.org/papers/thromboprophylaxis-with-low-molecular-weight-heparin-in-outpatients-with-plaster/)
- [Acute Hyperglycemia Causes Intracellular Formation of CML and Activation of ras, p42/44 MAPK, and Nuclear Factor κB in PBMCs](https://scholariq.org/papers/acute-hyperglycemia-causes-intracellular-formation-of-cml-and-activation-of-ras/)

## Researcher topics

- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diagnosis and Treatment of Venous Diseases](https://scholariq.org/topics/diagnosis-and-treatment-of-venous-diseases/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)

## Researcher university

- [Kantonsschule Olten](https://scholariq.org/institutions/kantonsschule-olten/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.